chr7-21854462-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001277115.2(DNAH11):​c.11202+7C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0248 in 1,611,074 control chromosomes in the GnomAD database, including 4,470 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.093 ( 1893 hom., cov: 32)
Exomes 𝑓: 0.018 ( 2577 hom. )

Consequence

DNAH11
NM_001277115.2 splice_region, intron

Scores

2
Splicing: ADA: 0.00009980
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.127

Publications

4 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 7-21854462-C-A is Benign according to our data. Variant chr7-21854462-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 163123.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.28 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.11202+7C>A splice_region_variant, intron_variant Intron 68 of 81 ENST00000409508.8 NP_001264044.1 Q96DT5Q96NT7H9NAJ8H9NAJ7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.11202+7C>A splice_region_variant, intron_variant Intron 68 of 81 5 NM_001277115.2 ENSP00000475939.1 Q96DT5
DNAH11ENST00000421290.1 linkn.385+7C>A splice_region_variant, intron_variant Intron 3 of 3 4
DNAH11ENST00000607413.5 linkn.465+7C>A splice_region_variant, intron_variant Intron 3 of 3 4

Frequencies

GnomAD3 genomes
AF:
0.0934
AC:
14182
AN:
151912
Hom.:
1894
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.285
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0348
Gnomad ASJ
AF:
0.00691
Gnomad EAS
AF:
0.220
Gnomad SAS
AF:
0.0118
Gnomad FIN
AF:
0.0303
Gnomad MID
AF:
0.0510
Gnomad NFE
AF:
0.00256
Gnomad OTH
AF:
0.0702
GnomAD2 exomes
AF:
0.0427
AC:
10571
AN:
247478
AF XY:
0.0359
show subpopulations
Gnomad AFR exome
AF:
0.291
Gnomad AMR exome
AF:
0.0238
Gnomad ASJ exome
AF:
0.00847
Gnomad EAS exome
AF:
0.221
Gnomad FIN exome
AF:
0.0303
Gnomad NFE exome
AF:
0.00253
Gnomad OTH exome
AF:
0.0246
GnomAD4 exome
AF:
0.0177
AC:
25775
AN:
1459044
Hom.:
2577
Cov.:
34
AF XY:
0.0162
AC XY:
11742
AN XY:
725618
show subpopulations
African (AFR)
AF:
0.293
AC:
9739
AN:
33272
American (AMR)
AF:
0.0247
AC:
1098
AN:
44502
Ashkenazi Jewish (ASJ)
AF:
0.00824
AC:
215
AN:
26098
East Asian (EAS)
AF:
0.218
AC:
8599
AN:
39522
South Asian (SAS)
AF:
0.00567
AC:
484
AN:
85422
European-Finnish (FIN)
AF:
0.0279
AC:
1486
AN:
53298
Middle Eastern (MID)
AF:
0.0184
AC:
106
AN:
5762
European-Non Finnish (NFE)
AF:
0.00161
AC:
1794
AN:
1110912
Other (OTH)
AF:
0.0374
AC:
2254
AN:
60256
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
893
1786
2679
3572
4465
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
448
896
1344
1792
2240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0933
AC:
14183
AN:
152030
Hom.:
1893
Cov.:
32
AF XY:
0.0933
AC XY:
6939
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.285
AC:
11776
AN:
41388
American (AMR)
AF:
0.0348
AC:
532
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00691
AC:
24
AN:
3472
East Asian (EAS)
AF:
0.220
AC:
1139
AN:
5166
South Asian (SAS)
AF:
0.0114
AC:
55
AN:
4812
European-Finnish (FIN)
AF:
0.0303
AC:
321
AN:
10588
Middle Eastern (MID)
AF:
0.0548
AC:
16
AN:
292
European-Non Finnish (NFE)
AF:
0.00254
AC:
173
AN:
67994
Other (OTH)
AF:
0.0695
AC:
147
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
528
1056
1584
2112
2640
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0345
Hom.:
291
Bravo
AF:
0.105
Asia WGS
AF:
0.107
AC:
372
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

11202+7C>A in intron 68 of DNAH11: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus se quence. It has been identified in 28.2% (1011/3586) of African American chromoso mes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs .washington.edu/EVS; dbSNP rs73279826). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
May 24, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.99
DANN
Benign
0.59
PhyloP100
0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00010
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73279826; hg19: chr7-21894080; COSMIC: COSV60946520; API